Stocks and Investing
by (remove) : Jonathan Chang
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Jonathan Chang
RSSJSONXMLCSV
Mon, August 22, 2022
Fri, August 12, 2022
Fri, August 5, 2022
Tue, June 7, 2022
Fri, May 13, 2022
Wed, May 11, 2022
Mon, May 9, 2022
Fri, May 6, 2022
Thu, April 21, 2022
Wed, March 30, 2022
Tue, March 15, 2022
Wed, March 2, 2022
Fri, December 17, 2021
Wed, November 10, 2021
Mon, November 1, 2021
Mon, September 13, 2021
Tue, September 7, 2021
Tue, August 10, 2021
Thu, August 5, 2021
Tue, June 1, 2021
Wed, April 14, 2021
Wed, February 3, 2021
Fri, November 6, 2020
Thu, November 5, 2020
Thu, September 10, 2020
Tue, September 8, 2020
Thu, August 6, 2020
Wed, August 5, 2020
Tue, May 7, 2019
Wed, March 28, 2018

Jonathan Chang Maintained (BCYC) at Buy with Increased Target to $50 on, Aug 22nd, 2022


Published on 2024-10-27 22:46:32 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Bicycle Therapeutics plc" (BCYC) at Buy with Increased Target from $48 to $50 on, Aug 22nd, 2022.

Jonathan has made no other calls on BCYC in the last 4 months.



There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Jonathan


  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $57 on, Friday, August 5th, 2022
  • Peter Lawson of "Barclays" Initiated at Buy and Held Target at $30 on, Thursday, July 28th, 2022
  • William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $60 on, Wednesday, July 6th, 2022
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Monday, May 23rd, 2022
Contributing Sources